Treatment with high concentrations of NaHS (600-1,000 μM) inhibits the (phosphatase and tensin homolog) PTEN/Akt signaling pathway, thereby inhibiting angiogenesis and tumor growth without causing significant systemic toxicity. Here, AKT1 is linked to neoplasm.